43 related articles for article (PubMed ID: 20067555)
1. Regulation of Raf activity by dimerization.
Wei H; Zhou MM
Pigment Cell Melanoma Res; 2010 Apr; 23(2):156-7. PubMed ID: 20067555
[No Abstract] [Full Text] [Related]
2. A genome-based strategy uncovers frequent BRAF mutations in melanoma.
Pollock PM; Meltzer PS
Cancer Cell; 2002 Jul; 2(1):5-7. PubMed ID: 12150818
[TBL] [Abstract][Full Text] [Related]
3. Wild-type and mutant B-RAF activate C-RAF through distinct mechanisms involving heterodimerization.
Garnett MJ; Rana S; Paterson H; Barford D; Marais R
Mol Cell; 2005 Dec; 20(6):963-9. PubMed ID: 16364920
[TBL] [Abstract][Full Text] [Related]
4. Cancer: enzymes play molecular tag.
Morrison DK
Nature; 2004 Apr; 428(6985):813-5. PubMed ID: 15103362
[No Abstract] [Full Text] [Related]
5. Novel C-Raf phosphorylation sites: serine 296 and 301 participate in Raf regulation.
Hekman M; Fischer A; Wennogle LP; Wang YK; Campbell SL; Rapp UR
FEBS Lett; 2005 Jan; 579(2):464-8. PubMed ID: 15642359
[TBL] [Abstract][Full Text] [Related]
6. Reduction in Raf kinase inhibitor protein expression is associated with increased Ras-extracellular signal-regulated kinase signaling in melanoma cell lines.
Schuierer MM; Bataille F; Hagan S; Kolch W; Bosserhoff AK
Cancer Res; 2004 Aug; 64(15):5186-92. PubMed ID: 15289323
[TBL] [Abstract][Full Text] [Related]
7. Lucky draw in the gene raffle.
Pollock PM; Meltzer PS
Nature; 2002 Jun; 417(6892):906-7. PubMed ID: 12087387
[No Abstract] [Full Text] [Related]
8. BRAF as a potential therapeutic target in melanoma and other malignancies.
Tuveson DA; Weber BL; Herlyn M
Cancer Cell; 2003 Aug; 4(2):95-8. PubMed ID: 12957284
[No Abstract] [Full Text] [Related]
9. B-RAF is a therapeutic target in melanoma.
Karasarides M; Chiloeches A; Hayward R; Niculescu-Duvaz D; Scanlon I; Friedlos F; Ogilvie L; Hedley D; Martin J; Marshall CJ; Springer CJ; Marais R
Oncogene; 2004 Aug; 23(37):6292-8. PubMed ID: 15208680
[TBL] [Abstract][Full Text] [Related]
10. Protein-protein recognition: an experimental and computational study of the R89K mutation in Raf and its effect on Ras binding.
Zeng J; Fridman M; Maruta H; Treutlein HR; Simonson T
Protein Sci; 1999 Jan; 8(1):50-64. PubMed ID: 10210183
[TBL] [Abstract][Full Text] [Related]
11. Raf: a strategic target for therapeutic development against cancer.
Beeram M; Patnaik A; Rowinsky EK
J Clin Oncol; 2005 Sep; 23(27):6771-90. PubMed ID: 16170185
[TBL] [Abstract][Full Text] [Related]
12. The RAF proteins take centre stage.
Wellbrock C; Karasarides M; Marais R
Nat Rev Mol Cell Biol; 2004 Nov; 5(11):875-85. PubMed ID: 15520807
[TBL] [Abstract][Full Text] [Related]
13. Domain shuffling as a tool for investigation of protein function: substitution of the cysteine-rich region of Raf kinase and PKC eta for that of yeast Pkc1p.
Schmitz HP; Jöckel J; Block C; Heinisch JJ
J Mol Biol; 2001 Aug; 311(1):1-7. PubMed ID: 11469853
[TBL] [Abstract][Full Text] [Related]
14. A dimeric 14-3-3 protein is an essential cofactor for Raf kinase activity.
Tzivion G; Luo Z; Avruch J
Nature; 1998 Jul; 394(6688):88-92. PubMed ID: 9665134
[TBL] [Abstract][Full Text] [Related]
15. Building insights into KRAS signaling complexes.
Hancock JF; Gorfe AA
Nat Struct Mol Biol; 2021 Oct; 28(10):773-774. PubMed ID: 34625745
[No Abstract] [Full Text] [Related]
16. A new class of supramolecular ligands stabilizes 14-3-3 protein-protein interactions by up to two orders of magnitude.
Gigante A; Grad JN; Briels J; Bartel M; Hoffmann D; Ottmann C; Schmuck C
Chem Commun (Camb); 2018 Dec; 55(1):111-114. PubMed ID: 30515494
[TBL] [Abstract][Full Text] [Related]
17. Raf kinases in lung tumor development.
Rapp UR; Fensterle J; Albert S; Götz R
Adv Enzyme Regul; 2003; 43():183-95. PubMed ID: 12791391
[No Abstract] [Full Text] [Related]
18. Raf-1 protein kinase, signal transduction, and targeted intervention of radiation response.
Kasid U
Exp Biol Med (Maywood); 2001 Jul; 226(7):624-5. PubMed ID: 11444096
[No Abstract] [Full Text] [Related]
19. Mutations of the BRAF gene in human cancer, by Davies et al. (Nature 2002; 417: 949-54).
Millington GW
Clin Exp Dermatol; 2013 Mar; 38(2):222-3. PubMed ID: 23397951
[No Abstract] [Full Text] [Related]
20. Tandem orthogonal chemically induced dimerization.
Voss S; Wu YW
Chembiochem; 2013 Sep; 14(13):1525-7. PubMed ID: 23939812
[No Abstract] [Full Text] [Related]
[Next] [New Search]
